TSG-6 (Tumor Necrosis Factor-α-Stimulated Gene/Protein-6): An Emerging Remedy for Renal Inflammation
Overview
Affiliations
The inflammatory response is a major pathological feature in most kidney diseases and often evokes compensatory mechanisms. Recent evidence suggests that TSG-6 (tumor necrosis factor-α-stimulated gene/protein-6) plays a pivotal role in anti-inflammation in various renal diseases, including immune-mediated and nonimmune-mediated renal diseases. TSG-6 has a diverse repertoire of anti-inflammatory functions: it potentiates antiplasmin activity of IαI (inter-α-inhibitor) by binding to its light chain, crosslinks hyaluronan to promote its binding to cell surface receptor CD44, and thereby regulate the migration and adhesion of lymphocytes, inhibits chemokine-stimulated transendothelial migration of neutrophils by directly interacting with the glycosaminoglycan binding site of CXCL8 (CXC motif chemokine ligand-8), and upregulates COX-2 (cyclooxygenase-2) to produce anti-inflammatory metabolites. Hopefully, further developments can target this anti-inflammatory molecule to the kidney and harness its remedial properties. This review provides an overview of the emerging role of TSG-6 in blunting renal inflammation.
Kopac M, Jerin A, Petrera A, Osredkar J Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996798 PMC: 11854277. DOI: 10.3390/cimb47020077.
Song H, Li Z, Huang Q, Wu C, Li M, Shen J Ann Med. 2024; 57(1):2443568.
PMID: 39704340 PMC: 11703038. DOI: 10.1080/07853890.2024.2443568.
Identification of TNFAIP6 as a reliable prognostic indicator of low-grade glioma.
Huang Q, Liang H, Shi S, Ke Y, Wang J Heliyon. 2024; 10(12):e33030.
PMID: 38948040 PMC: 11211890. DOI: 10.1016/j.heliyon.2024.e33030.
Ilg M, Bustin S, Ralph D, Cellek S Sci Rep. 2024; 14(1):12389.
PMID: 38811625 PMC: 11136978. DOI: 10.1038/s41598-024-62123-x.
Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease.
Wei S, Li M, Wang Q, Zhao Y, Du F, Chen Y J Inflamm Res. 2024; 17:3307-3334.
PMID: 38800593 PMC: 11128225. DOI: 10.2147/JIR.S458103.